Icon of a newspaper

In the news

Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Takara, Clontech, and Cellartis brands. To keep you up to date with the latest happenings at Takara Bio USA, we have compiled our recent announcements and press releases below.


Takara Bio USA, Inc. validates new class of spatial technology with benchmark study for cancer research

Date: April 20, 2026

Categories: Press release

First in a series of benchmarking studies shows superior performance of Trekker FX in an FFPE lung squamous cell carcinoma sample

Read More


Takara Bio USA, Inc. launches certified service provider program to advance research using NGS and single-cell technologies

Date: April 16, 2026

Categories: Press release

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta single-cell and bulk RNA-seq NGS solutions

Read More


Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation

Date: March 30, 2026

Categories: Press release

Takara Bio USA and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide.

Read More


Takara Bio USA, Inc. collaborates with Illumina on spatial transcriptomics workflow, details presented at AGBT 2026

Date: February 26, 2026

Categories: Press release

Integration of Takara Bio USA’s Trekker reagent kit with Illumina’s Single Cell 3′ RNA Prep assay delivers high-density, high-sensitivity spatial data with true single-cell resolution.

Read More


Takara Bio USA, Inc. announces a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology

Date: October 8, 2025

Categories: Press release

Takara Bio USA, Inc. announced a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology.

Read More


Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Date: January 15, 2025

Categories: Press release

Takara Bio USA Holdings, Inc. announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.

Read More


Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research

Date: November 19, 2024

Categories: Press release

Takara Bio USA announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for infectious disease research.

Read More


Takara Bio Europe unveils new large-scale NGS profiling system and chemistries

Date: September 26, 2024

Categories: Press release

Takara Bio Europe announces the launch of the Shasta Single-Cell System at the 2024 Human Cell Atlas General Meeting.

Read More


Takara Bio launches large-scale, flexible qPCR system to advance broad surveillance of antimicrobial resistance

Date: September 4, 2024

Categories: Press release

Takara Bio USA, Inc. announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for monitoring antimicrobial resistance (AMR), supporting efforts to ensure environmental safety and sustainability.

Read More


Jumpcode Genomics and Takara Bio USA announce global patent partnership

Date: June 13, 2024

Categories: Press release

Jumpcode Genomics and Takara Bio USA announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS libraries using CRISPR-based technology.

Read More